OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 Stage 0 melanoma in a mole vs not in mole
  2. 2 Stage 0 melanoma in a mole vs not in mole life expectancy difference

Answered on this page ↓

Stage 0 melanoma in a mole vs not in mole life expectancy difference

Nov 1, 2026 · 2 sources used · OpenNeedle synthesis
The short version: I can't give you a life-expectancy difference, because the evidence in front of me doesn't measure survival by where a stage 0 melanoma started.

The closest real data compares mole-associated melanomas to melanomas on normal skin, but it counts how thick they were, not how long people lived. In one 15-year series of about 2,000 melanomas, 8.4% arose in a mole and 91.6% started on normal skin [1]. The mole-associated ones were thinner on average, 0.83 mm versus 0.97 mm [1]. Thinner is better, but thickness is a stand-in for outcome, not the outcome itself.

FindingIn a moleOn normal skin
Share of all melanomas8.4% [1]91.6% [1]
Mean thickness0.83 mm [1]0.97 mm [1]
Stage 0 share24.5% [1]35.2% [1]

Notice the twist: stage 0 was actually more common among the normal-skin melanomas, 35.2% versus 24.5% [1]. So the "caught earlier because it was watched" story doesn't hold up cleanly here.

For stage 0 itself, the records show it is treated by complete removal, and upstaging to invasive disease at excision happened in 23% of 570 lesions across the reviewed studies [2]. That is the number that matters for your question, not the mole origin.

My call: no life-expectancy difference can be stated from this evidence, and the mole-versus-normal-skin distinction is not the lever that decides survival at stage 0. Confidence: low.

Keep digging

Sources used 2

  1. Cutaneous melanoma associated with naevi prevalence: A 15‐year cross‐sectional retrospective study Australasian Journal of Dermatology (2019) Thin

    A 15-year retrospective cross-sectional study at the University of Naples Federico II assessing the prevalence of nevus-associated melanoma among cutaneous melanomas and comparing NAM with de novo melanoma in terms of age, site, Breslow thickness, and histology.

    DOI: 10.1111/ajd.13171
  2. Mohs Surgery for the Treatment of Melanoma in Situ: A Review Dermatologic Surgery (2007) Thin

    A comprehensive literature review assessing Mohs micrographic surgery for melanoma in situ (MIS), focusing on margin requirements, the rate of upstaging MIS to invasive melanoma after complete excision, the role of immunostains and alternative margin assessment techniques, and r…

    DOI: 10.1111/j.1524-4725.2007.33085.x

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →